Results 201 to 210 of about 253,218 (253)
Some of the next articles are maybe not open access.

Biomarkers in Duchenne Muscular Dystrophy

Current Heart Failure Reports, 2022
This review highlights the key studies investigating various types of biomarkers in Duchenne muscular dystrophy (DMD).Several proteomic and metabolomic studies have been undertaken in both human DMD patients and animal models of DMD that have identified potential biomarkers in DMD.
Theo, Lee-Gannon   +3 more
openaire   +2 more sources

Casimersen for Duchenne muscular dystrophy

Drugs of Today, 2021
Duchenne muscular dystrophy (DMD) is a genetic disorder affecting 1 in 5,000 males which causes progressive muscle deterioration, loss of mobility and eventual death, with an average lifespan of around 25 years. While no cure currently exists for DMD, a novel treatment known as antisense-mediated exon skipping therapy has shown great promise.
H, Wilton-Clark, T, Yokota
openaire   +2 more sources

Duchenne muscular dystrophy

1995
Duchenne and Becker muscular dystrophy are X-linked muscle-wasting disorders that arise from mutations in the gene coding for dystrophin. The incidence of Duchenne muscular dystrophy (DMD) is approximately 1 in 3500 live male births, one-third of which are sporadic with no previous family history. In the absence of dystrophin, patients with DMD exhibit
G, Dickson, S C, Brown
openaire   +2 more sources

Duchenne muscular dystrophy

Current Opinion in Genetics & Development, 1991
Progress in understanding the role of dystrophin raises promising hopes for a treatment for Duchenne muscular dystrophy. In addition, great improvements have been made in the ability to diagnose this disease using simple molecular methods.
openaire   +2 more sources

Duchenne muscular dystrophy

Biochemical Society Transactions, 1984
What is Duchenne muscular dystrophy? Duchenne muscular dystrophy is a muscle-wasting condition caused by the lack of a protein called dystrophin. It usually affects only boys. About 100 boys with Duchenne muscular dystrophy are born in the UK each year and there are about 2,500 boys and young men known to be living with the condition in the UK at any ...
openaire   +2 more sources

Muscular fatigue in Duchenne muscular dystrophy

Neurology, 1995
We used a 4-minute sustained maximum voluntary contraction to investigate fatigability of the anterior tibial muscle in eight healthy boys and 11 boys with Duchenne muscular dystrophy (DMD) (ages 5 to 10 years). Before exercise, the force generation of dystrophic muscle and the compound muscle action potential amplitude were lower and half-relaxation ...
K R, Sharma, M A, Mynhier, R G, Miller
openaire   +2 more sources

Duchenne Muscular Dystrophy

Journal of the American Academy of Orthopaedic Surgeons, 2002
Duchenne muscular dystrophy is an X-linked disease of muscle caused by an absence of the protein dystrophin. Affected boys begin manifesting signs of disease early in life, cease walking at the beginning of the second decade, and usually die by age 20 years. Until treatment of the basic genetic defect is available, medical, surgical, and rehabilitative
openaire   +2 more sources

Duchenne muscular dystrophy

Human Genetics, 1977
By a general survey in the hopitals of northeast Italy, Duchenne cases have been located and identified over a 20-year period. In a more restricted area screening for Duchenne carriers has been carried out in affected families. This procedure made possible an exact estimate of the incidence rate, prevalence rate, and mutation rate in a large sample of ...
Danieli GA   +3 more
openaire   +2 more sources

Neuroblastoma in Duchenne Muscular Dystrophy

Pediatrics, 1986
To the Editor.— In reporting two patients with neuroblastoma and cystic fibrosis, Moss et al1 noted that "reports of cystic fibrosis and other genetic abnormalities in individual patients are usually regarded as chance associations." We encountered an analogous situation in caring for a boy in whom stage III neuroblastoma ...
K M, Johnston   +3 more
openaire   +2 more sources

Echocardiography in duchenne muscular dystrophy

Muscle & Nerve, 1980
AbstractThe cardiac function of 36 males with Duchenne muscular dystrophy was evaluated by echocardiography, and the results were compared with the results of other tests of cardiac involvement, including serum creatine kinase isoenzyme evaluation, electrocardiography, chest x‐ray, and physical examination of the heart and lungs.
D, Danilowicz   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy